Vigabatrin therapy in patient with succinic semialdehyde dehydrogenase deficiency

Lancet. 1989 Nov 4;2(8671):1105-6. doi: 10.1016/s0140-6736(89)91126-4.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Aldehyde Oxidoreductases
  • Aminocaproates
  • Anticonvulsants / therapeutic use*
  • Child, Preschool
  • Humans
  • Male
  • Metabolism, Inborn Errors / enzymology
  • Metabolism, Inborn Errors / urine
  • Sodium Oxybate / urine
  • Succinate-Semialdehyde Dehydrogenase
  • Vigabatrin

Substances

  • Aminocaproates
  • Anticonvulsants
  • Sodium Oxybate
  • Aldehyde Oxidoreductases
  • ALDH5A1 protein, human
  • Succinate-Semialdehyde Dehydrogenase
  • Vigabatrin